Enterobacteriaceae cause a wide range of diseases including urinary tract infections, respiratory tract infections, sepsis, and gastroenteritis. They are the most frequently recovered pathogens from clinical samples and have varying susceptibility patterns. The study set out to determine the susceptibility profile of enterobacteriaceae species at the Babcock University Teaching Hospital. Enterobacteriaceae were identified using the Microbact 12A kit (Oxoid UK) and susceptibility was determined with the modified Kirby-Bauer Method in line with CLSI 2014 guidelines. Escherichia coli the main isolate was 100% susceptible to Piperacillin/Tazobactam, 94% susceptible to Amikacin, 76.5% susceptible to both Ampicillin/Sulbactam and Ceftazidime, 70.6% susceptible to Ceftriaxone and Meropenem, 67% susceptible to Ciprofloxacin, 58% Susceptible to Gentamicin and 23.5% susceptible to Amoxicillin/Clavulanic acid. Antibiotic resistance among Enterobacteriaceae is on the rise in Babcock University Teaching Hospital. Measures should be put in place to prevent more resistance and to prevent spread of resistant strains.
Published in | American Journal of Biomedical and Life Sciences (Volume 3, Issue 6) |
DOI | 10.11648/j.ajbls.20150306.15 |
Page(s) | 127-130 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2016. Published by Science Publishing Group |
Antimicrobial Resistance, Escherichia Coli, Enterobacteriaceae, Babcock University
[1] | Williams & Wilkins (1984). The Gammaproteobacteria. In George M. Garrity, editor. Bergey's Manual of Systematic Bacteriology 2B (2nd ed.). New York: Springer. p. 1108. ISBN 978-0-387-24144-9. British Library no. GBA561951. |
[2] | Aeschlmann (2003). The role of Multidrug Efflux Pumps in the Antibiotic Resistance of Pseudomonas aeruginosa and other Gram negative bacteria. Pharmacotherapy 22(7): 916-924. |
[3] | Fleming A (1945) Penicillin. Nobel Lecture delivered December 11, 1945. |
[4] | Fluit ADC, Visser MR, Schmitz FJ (2001) Molecular Detection of Antimicrobial resistance. Clinical Microbiology Reviews 14(4): 836-871. |
[5] | Forbes BA, Sahm DF, Weissfeld AS (1998) Bailey And Scott’s Diagnostic Microbiology, 10th edn. Mosby Inc., St. Louis Missouri, USA. |
[6] | Giguère S (2006). Antimicrobial Drug Action and Interaction: An Introduction. Antimicrobial therapy in Veterinary Medicine 4th edn, S Giguère, JF Prescott, JD. |
[7] | Gillespie SH (2001) Antibotic Resistance in the Absence of selective Pressure. International Journal of Antimicrobial Agents 17: 171-176. |
[8] | Higgins CF (2007). Multiple Molecular Mechanisms for Multidrug resistance Transporters. Nature 446749-757. |
[9] | Kolář M, Urbánek K, Látal T (2001) Antibiotic selective pressure and development of bacterial resistance. International Journal of Antimicrobial Agents 17 (5): 357–363. |
[10] | Kumar A and Schweizer HP (2005) Bacterial Resistance to Antibiotics: Active Efflux and Reduced Uptake. Advanced Drug Delivery Reviews 57: 1486-1513. 17: 357-363. |
[11] | Lambert PA (2005) Bacterial resistance to Antibiotics: Modified Target Sites. Advanced Drug Delivery Review. 57: 1471-1485. |
[12] | Levy SB (2002) The Antibiotic Paradox, 2nd edition. Perseus Publishing, USA. |
[13] | Alekshun MN and Levy S (2007) Molecular Mechanisms of Antibacterial Multidrug Resistance. Cell 128: 1037-1050. |
[14] | Williams KP, Gillespie JJ, Sobral BWS, Nordberg EK, Snyder EE, Shallom JM, Dickerman AW (2010) "Phylogeny of Gamma-proteobacteria". Journal of Bacteriology 192 (9): 2305–2314. |
[15] | Martinez JL and Baquero F (2000) Mutation frequencies and antibiotic resistance. Antimicrobial Agents and Chemotherapy 44(7): 1771-1777. |
[16] | Nordmann P and Poirel L (2005) Emergence of Plasmid-Mediated Resistance to Quinolones in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 56: 463–469. |
[17] | Poole K (2005) Efflux-mediated Antimicrobial Resistance. Journal of Antimicrobial Chemotherapy 56: 20-51. |
[18] | Roe MT and Pillai SD (2003) Monitoring and Identifying Antibiotic resistance Mechanisms in Bacteria. Poultry Science 82: 622-626. |
[19] | Rouveix B (2007) Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria. Journal of Antimicrobial Chemotherapy 59: 1208-1209. |
[20] | Sköld O (2000) Sulfonamide Resistance: Mechanisms and Trends. Drug Resistance Updates 3: 155-160. |
[21] | Turnidge J and Peterson DL (2007). Setting and Revising Antibacterial Susceptibility Breakpoints. Clinical Microbiology Reviews 20 (3): 391-408. |
[22] | Walsh C (2000) Molecular Mechanisms that Confer Antibacterial Drug Resistance. Nature 406: 775-781. |
[23] | Watts JL and Lindeman CJ (2006) Antimicrobial Susceptibility Testing of Bacteria of Veterinary Origin. In Aarestrup F, editors. Antimicrobial Resistance in Bacteria of Animal Origin. ASM Press, Washington, DC. 29-36. |
[24] | White DG, McDermott PF and Walker RD (2003) Antimicrobial Susceptibility Testing Methodologies. In Torrence ME and Isaacson RE, editors. Microbial food Safety in Animal Agriculture. Wiley online library. DOI: 10.1002/9780470752616.ch5. |
[25] | Baquero F and Blàazquez J (1997) Evolution of Antibiotic Resistance. Trends in Ecology and Evolution 12(12): 482-487. |
[26] | Witte W (2000) Selective Pressure by Antibiotic Use in Livestock. International Journal of Antimicrobial Agents 16: 519-524. |
[27] | Berger-Bächi B. 2002. Resistance Mechanisms of Gram Positive Bacteria. International Journal of Medical Microbiology. 292: 27-35. |
[28] | Papp-Wallace, K. M. et al., 2010. Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Antimicrobial agents and chemotherapy, 54(2), pp. 890–7. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2812178 & tool=pmcentrez & rendertype=abstract. |
[29] | MacFaddin JF (2000) Biochemical Tests for Identification of Medical Bacteria, 3rd edition. Lippincott Williams & Wilkins 912p. |
[30] | Centers for Disease Control and Prevention - Klebsiella Quotation: "Increasingly, Klebsiella bacteria have developed antimicrobial resistance, most recently to the class of antibiotics known as carbapenems. |
[31] | Dyar, O. J. et al., 2012. High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam. BMC infectious diseases, 12, p. 92. |
[32] | Depardieu F, Podglajen, Leclercq R, Collatz E and Courvalin P (2007) Modes and Modulations of Antibiotic resistance Gene Expression. Clinical Microbiology. 20 (1): 79-114. |
[33] | Fàbrega A, Sànchez-Cespedes J, Soto S and Vila Jordi (2008) Quinolone Resistance in the Food Chain. International Journal of Antimicrobial Agents. 31: 307-311. |
[34] | Cheng, W. et al., 2013. Abundance and persistence of antibiotic resistance genes in livestock farms: A comprehensive investigation in eastern China. Environment International, 61, pp. 1–7. |
[35] | Prescott JF (2006) Beta-lactam antibiotics: Penam penicillins. In Giguère S, Prescott JF, Baggot JD, Walker RD, Dowling M, editors. Antimicrobial Therapy in Veterinary Medicine. Ames, IA: Blackwell Publishing. Page 124. |
[36] | Rinsky, J. L. et al., 2013. Livestock-Associated Methicillin and Multidrug Resistant Staphylococcus aureus Is Present among Industrial, Not Antibiotic-Free Livestock Operation Workers in North Carolina. PLoS ONE, 8 (7), pp. 1–11. |
[37] | Cordoba, G. et al., 2015. Prescribing style and variation in antibiotic prescriptions for sore throat: cross-sectional study across six countries. BMC family practice, 16, p. 7. |
[38] | Barnett, M. L. & Linder, J. a, 2014. Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010. JAMA, 311 (19), pp. 2020–2. |
APA Style
Charles John Elikwu, Emmanuel Olushola Shobowale, Victor Ugochukwu Nwadike, Babatunde Tayo, Chika Celen Okangba, et al. (2016). Antimicrobial Susceptibility Patterns of Enterobacteriaceae Isolated from Stool Samples at a Semi-urban Teaching Hospital. American Journal of Biomedical and Life Sciences, 3(6), 127-130. https://doi.org/10.11648/j.ajbls.20150306.15
ACS Style
Charles John Elikwu; Emmanuel Olushola Shobowale; Victor Ugochukwu Nwadike; Babatunde Tayo; Chika Celen Okangba, et al. Antimicrobial Susceptibility Patterns of Enterobacteriaceae Isolated from Stool Samples at a Semi-urban Teaching Hospital. Am. J. Biomed. Life Sci. 2016, 3(6), 127-130. doi: 10.11648/j.ajbls.20150306.15
AMA Style
Charles John Elikwu, Emmanuel Olushola Shobowale, Victor Ugochukwu Nwadike, Babatunde Tayo, Chika Celen Okangba, et al. Antimicrobial Susceptibility Patterns of Enterobacteriaceae Isolated from Stool Samples at a Semi-urban Teaching Hospital. Am J Biomed Life Sci. 2016;3(6):127-130. doi: 10.11648/j.ajbls.20150306.15
@article{10.11648/j.ajbls.20150306.15, author = {Charles John Elikwu and Emmanuel Olushola Shobowale and Victor Ugochukwu Nwadike and Babatunde Tayo and Chika Celen Okangba and Opeoluwa Akinyele Shonekan and Azubuike Chidiebere Omeonu and Bibitayo Faluyi and Pearl Ile and Adebola Adelodun and Adebusola Popoola and Maxwell Mubele}, title = {Antimicrobial Susceptibility Patterns of Enterobacteriaceae Isolated from Stool Samples at a Semi-urban Teaching Hospital}, journal = {American Journal of Biomedical and Life Sciences}, volume = {3}, number = {6}, pages = {127-130}, doi = {10.11648/j.ajbls.20150306.15}, url = {https://doi.org/10.11648/j.ajbls.20150306.15}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20150306.15}, abstract = {Enterobacteriaceae cause a wide range of diseases including urinary tract infections, respiratory tract infections, sepsis, and gastroenteritis. They are the most frequently recovered pathogens from clinical samples and have varying susceptibility patterns. The study set out to determine the susceptibility profile of enterobacteriaceae species at the Babcock University Teaching Hospital. Enterobacteriaceae were identified using the Microbact 12A kit (Oxoid UK) and susceptibility was determined with the modified Kirby-Bauer Method in line with CLSI 2014 guidelines. Escherichia coli the main isolate was 100% susceptible to Piperacillin/Tazobactam, 94% susceptible to Amikacin, 76.5% susceptible to both Ampicillin/Sulbactam and Ceftazidime, 70.6% susceptible to Ceftriaxone and Meropenem, 67% susceptible to Ciprofloxacin, 58% Susceptible to Gentamicin and 23.5% susceptible to Amoxicillin/Clavulanic acid. Antibiotic resistance among Enterobacteriaceae is on the rise in Babcock University Teaching Hospital. Measures should be put in place to prevent more resistance and to prevent spread of resistant strains.}, year = {2016} }
TY - JOUR T1 - Antimicrobial Susceptibility Patterns of Enterobacteriaceae Isolated from Stool Samples at a Semi-urban Teaching Hospital AU - Charles John Elikwu AU - Emmanuel Olushola Shobowale AU - Victor Ugochukwu Nwadike AU - Babatunde Tayo AU - Chika Celen Okangba AU - Opeoluwa Akinyele Shonekan AU - Azubuike Chidiebere Omeonu AU - Bibitayo Faluyi AU - Pearl Ile AU - Adebola Adelodun AU - Adebusola Popoola AU - Maxwell Mubele Y1 - 2016/01/11 PY - 2016 N1 - https://doi.org/10.11648/j.ajbls.20150306.15 DO - 10.11648/j.ajbls.20150306.15 T2 - American Journal of Biomedical and Life Sciences JF - American Journal of Biomedical and Life Sciences JO - American Journal of Biomedical and Life Sciences SP - 127 EP - 130 PB - Science Publishing Group SN - 2330-880X UR - https://doi.org/10.11648/j.ajbls.20150306.15 AB - Enterobacteriaceae cause a wide range of diseases including urinary tract infections, respiratory tract infections, sepsis, and gastroenteritis. They are the most frequently recovered pathogens from clinical samples and have varying susceptibility patterns. The study set out to determine the susceptibility profile of enterobacteriaceae species at the Babcock University Teaching Hospital. Enterobacteriaceae were identified using the Microbact 12A kit (Oxoid UK) and susceptibility was determined with the modified Kirby-Bauer Method in line with CLSI 2014 guidelines. Escherichia coli the main isolate was 100% susceptible to Piperacillin/Tazobactam, 94% susceptible to Amikacin, 76.5% susceptible to both Ampicillin/Sulbactam and Ceftazidime, 70.6% susceptible to Ceftriaxone and Meropenem, 67% susceptible to Ciprofloxacin, 58% Susceptible to Gentamicin and 23.5% susceptible to Amoxicillin/Clavulanic acid. Antibiotic resistance among Enterobacteriaceae is on the rise in Babcock University Teaching Hospital. Measures should be put in place to prevent more resistance and to prevent spread of resistant strains. VL - 3 IS - 6 ER -